Progress and controversies in the treatment of oligometastatic disease of pancreatic cancer
10.3760/cma.j.cn113855-20241011-00617
- VernacularTitle:胰腺癌寡转移性疾病治疗的进展与争议
- Author:
Guihu WENG
1
;
Yueze LIU
1
;
Taiping ZHANG
1
Author Information
1. 中国医学科学院北京协和医学院北京协和医院基本外科，北京 100730
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Surgical procedures,operative;
Oligometastatic disease;
Progress and controversies
- From:
Chinese Journal of General Surgery
2025;40(1):37-41
- CountryChina
- Language:Chinese
-
Abstract:
The onset of pancreatic cancer is insidious, and most patients have accompanied by distant metastasis at the time of definite diagnosis. Previously, it was believed that regardless of the size, number and location of metastases, the surgical benefits of patients with metastatic pancreatic cancer were extremely limited. However, with the promotion of the concept of oligometastasis in recent years, an increasing number of studies have confirmed that surgical resection after induction therapy can significantly improve the clinical prognosis in some highly selected patients with oligometastatic disease of pancreatic cancer. However, there still remains many controversies about the clear definition, surgical treatment and perioperative management of oligometastatic disease of pancreatic cancer. Therefore, based on the latest research progress, this article proposes to discuss the related hot topics and disputes in the field of oligometastatic disease of pancreatic cancer for purpose of promoting the standardization of the treatment of oligometastatic disease of pancreatic cancer.
